Monitoring of neuromuscular blockade during general anaesthesia after reversal with neostigmine

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517831-28-00

Enrollment

120

Registered

2024-09-17

Start date

2025-01-01

Completion date

Unknown

Last updated

2024-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incidence of reappearance of the muscle relaxation after reversal with neostigmine

Brief summary

To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine

Interventions

DRUGGLYCOSTIGMIN -injektioneste

DRUGliuos

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
To find the incidence of reappearance of nondepolarizing neuromuscular block after reversal with neostigmine	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026